US Stock MarketDetailed Quotes
HLVX HilleVax
- 12.790
- +0.770+6.41%
Close Apr 26 16:00 ET
- 12.790
- 0.0000.00%
Post 16:20 ET
635.93MMarket Cap-4207P/E (TTM)
13.200High11.989Low369.59KVolume12.580Open12.020Pre Close4.66MTurnover1.48%Turnover RatioLossP/E (Static)49.72MShares20.22052wk High2.40P/B320.07MFloat Cap9.94052wk Low--Dividend TTM25.03MShs Float24.420Historical High--Div YieldTTM10.07%Amplitude7.900Historical Low12.606Avg Price1Lot Size
HilleVax Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -40.00%-86.78M | -16.68%-21.61M | -37.14%-26.81M | -69.70%-22.42M | -48.89%-15.95M | -749.75%-61.99M | -341.51%-18.52M | -1,149.01%-19.55M | -1,080.52%-13.21M | -2,469.54%-10.72M |
| Net income from continuing operations | 22.68%-123.57M | -74.44%-36.96M | -89.32%-31.82M | 48.26%-27.9M | 60.39%-26.89M | -56.05%-159.81M | 43.24%-21.19M | 72.84%-16.81M | -3,135.09%-53.93M | -4,291.14%-67.89M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 68.33%43.62M | --0 | --0 | --6.15M | --37.47M |
| Depreciation and amortization | 87.80%2.16M | 132.05%724K | 61.23%653K | 0.00%418K | 2,676.92%361K | 38,166.67%1.15M | 15,500.00%312K | --405K | --418K | --13K |
| Other non cash items | -97.95%1.12M | 121.48%330K | 153.91%325K | -99.30%240K | -98.88%220K | -6.06%54.35M | -99.21%149K | -99.67%128K | 7,669.82%34.5M | 26,712.33%19.57M |
| Change In working capital | 631.73%22.84M | 1,218.43%11.59M | 132.97%1.36M | 341.59%2.18M | 5,173.68%7.71M | -138.10%-4.3M | -90.18%879K | -453.87%-4.12M | -977.67%-904K | -114.39%-152K |
| -Change in prepaid assets | 136.28%4.02M | 150.96%1.59M | 106.37%204K | 107.44%328K | 659.00%1.9M | -9,443.97%-11.07M | -3,291.30%-3.12M | -4,980.95%-3.2M | -15,310.34%-4.41M | -3,490.00%-339K |
| -Change in payables and accrued expense | 155.39%14.48M | 179.44%9.95M | 48.77%-646K | -75.75%770K | 2,148.98%4.41M | -50.22%5.67M | -60.62%3.56M | -202.52%-1.26M | 4,190.54%3.18M | -81.26%196K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | 15,755.56%1.41M | ---- | ---- | ---- | ---- | ---9K |
| -Change in other working capital | 293.39%4.34M | -89.04%48K | 424.78%1.8M | ---- | ---- | --1.1M | --438K | --343K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -40.00%-86.78M | -16.68%-21.61M | -37.14%-26.81M | -69.70%-22.42M | -48.89%-15.95M | -749.75%-61.99M | -341.51%-18.52M | -1,149.01%-19.55M | -1,080.52%-13.21M | -2,469.54%-10.72M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,352.84%-94.64M | 869.63%29.47M | -16,750.81%-31.17M | -89.95M | -19.40%-2.99M | -131.98%-6.51M | -12,663.33%-3.83M | 93.33%-185K | 0 | -2.5M |
| Net PPE purchase and sale | -167.76%-10.75M | 80.73%-738K | -1,081.62%-2.19M | ---4.84M | ---2.99M | -8,820.00%-4.01M | -12,663.33%-3.83M | -1,955.56%-185K | --0 | --0 |
| Net intangibles purchase and sale | --0 | --0 | --0 | --0 | --0 | 9.52%-2.5M | --0 | --0 | --0 | ---2.5M |
| Net investment purchase and sale | ---83.89M | --30.21M | ---28.99M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,352.84%-94.64M | 869.63%29.47M | -16,750.81%-31.17M | ---89.95M | -19.40%-2.99M | -131.98%-6.51M | -12,663.33%-3.83M | 93.33%-185K | --0 | ---2.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -47.24%118.7M | -96.77%313K | 3,933.58%108.11M | -95.33%10.2M | 180.81%80K | 67.62%224.97M | 1,327.76%9.69M | -102.12%-2.82M | 12,361.51%218.2M | -99K |
| Net issuance payments of debt | -33.17%9.8M | --0 | --0 | ---- | ---- | -89.14%14.67M | --10M | --0 | ---- | ---- |
| Net common stock issuance | -53.14%107.79M | ---310K | --108.1M | ---- | ---- | 23,000,500.00%230.01M | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --1.11M | --623K | --7K | --398K | --80K | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -2,397.08%-19.7M | ---313K | ---2.82M | ---16.47M | ---99K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -47.24%118.7M | -96.77%313K | 3,933.58%108.11M | -95.33%10.2M | 180.81%80K | 67.62%224.97M | 1,327.76%9.69M | -102.12%-2.82M | 12,361.51%218.2M | ---99K |
| Net cash flow | ||||||||||
| Beginning cash position | 125.61%281.03M | -28.45%210.13M | -49.40%160.01M | 135.66%262.17M | 125.61%281.03M | 27,157.33%124.57M | 126.65%293.69M | 47,383.93%316.24M | 278,030.00%111.25M | 27,157.33%124.57M |
| Current changes in cash | -140.09%-62.72M | 164.59%8.18M | 322.27%50.13M | -149.84%-102.17M | -41.65%-18.86M | 26.07%156.47M | -152.52%-12.66M | -117.49%-22.55M | 32,646.17%204.99M | -3,092.81%-13.31M |
| End cash Position | -22.32%218.31M | -22.32%218.31M | -28.45%210.13M | -49.40%160.01M | 135.66%262.17M | 125.61%281.03M | 125.61%281.03M | 126.65%293.69M | 47,383.93%316.24M | 278,030.00%111.25M |
| Free cash flow | -42.37%-97.53M | 0.01%-22.34M | -46.93%-28.99M | -106.33%-27.26M | -43.31%-18.94M | -578.05%-68.5M | -429.02%-22.35M | -354.97%-19.73M | -1,074.22%-13.21M | -3,069.06%-13.22M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg